A prospective, randomized study comparing standard dosing and genotype dosing of warfarin therapy

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: LEE, Kyungeun (Chungbuk National University, College of Pharmacy, Cheongju-si, Korea, Republic Of)
  • Co-author(s): Kyung Eun Lee: College of Pharmacy, Chungbuk National University, Cheongju-si, Korea, Republic Of
    Gwan Yung Lee: College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea, Republic Of
    Jee Eun Chung: College of Pharmacy, Sungkyunkwan University, Suwon-si, Korea, Republic Of
    Jeong Yee: College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea, Republic Of
    Hyun Jeong Kim: College of Pharmacy, Chungbuk National University, Cheongju-si, Korea, Republic Of
    Joo Hee Kim: College of Pharmacy, Ajou University, Suwon, Korea, Republic Of
    Hye Sun Gwak: College of Pharmacy and Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea, Republic Of
    Byung Chul Chang: Department of Thoracic & Cardiovascular Surgery, Yonsei University Medical Center, Seoul, Korea, Republic Of
  • Abstract:

    Background

    The level of anticoagulation in response to a fixed-dose regimen of warfarin is challenging. 

    Purpose

    We aimed to prospectively compare the effectiveness of genotype-based initial warfarin dosing with that of standard dosing in patients starting warfarin therapy.

    Methods

    We conducted a randomized, controlled trial involving patients with..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login